Status:
RECRUITING
Validation of Continuous Transcutaneous Carbon Dioxide Monitoring in VA-ECMO Patients
Lead Sponsor:
Medical University of Vienna
Conditions:
Carbon Dioxide
Eligibility:
All Genders
18-90 years
Brief Summary
Carbon dioxide in patients on veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is eliminated via respirator as well as via the oxygenator's membrane of the ECMO machine. Consequently, monit...
Detailed Description
After documenting the characteristics of participants, cannulation site, and the cause for ECMO support, transcutaneous, arterial, venous, as well as end-tidal carbon dioxide partial pressure values a...
Eligibility Criteria
Inclusion
- Low cardiac output requiring VA-ECMO support.
Exclusion
- Age \< 18 years
Key Trial Info
Start Date :
November 18 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04445909
Start Date
November 18 2019
End Date
December 31 2025
Last Update
December 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, 1090